Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancer. | Cancer Genet | 2025 | 40527113 | PubTator, text mining | PubMed |
| Practical implementation of AI in a non-academic, non-commercial Pathology laboratory: Real world experience and lessons learned. | Histopathology | 2025 | 40525301 | PubTator, text mining | PubMed |
| RBAP48 facilitates the oral squamous cell carcinoma process in an androgen receptor-dependent and independent manners. | Commun Biol | 2025 | 40442479 | PubTator, text mining | PubMed |
| Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS. | Genet Epidemiol | 2025 | 40407036 | PubTator, text mining | PubMed |
| Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. | BMC Gastroenterol | 2025 | 40375142 | PubTator, text mining | PubMed |
| Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors. | Nat Commun | 2025 | 40374594 | PubTator, text mining | PubMed |
| Single-cell mass spectrometry imaging of lipids in HeLa cells via tapping-mode scanning probe electrospray ionization. | Commun Chem | 2025 | 40369247 | PubTator, text mining | PubMed |
| iDDN: determining trans-omics network structure and rewiring with integrative differential dependency networks. | Bioinform Adv | 2025 | 40365110 | PubTator, text mining | PubMed |
| Mass spectrometry-based metabolomic as a powerful tool to unravel the component and mechanism in TCM. | Chin Med | 2025 | 40355943 | PubTator, text mining | PubMed |
| The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy Response. | Int J Mol Sci | 2025 | 40244273 | PubTator, text mining | PubMed |
| Integration Strategies and Formats in Field-Effect Transistor Chemo- and Biosensors: A Critical Review. | ACS Sens | 2025 | 40232361 | PubTator, text mining | PubMed |
| CT Lymph Node Patterns in MSI-High Colon Cancer: A Potential Solution to a Mystery. | Radiology | 2025 | 40197099 | PubTator, text mining | PubMed |
| Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy. | Front Immunol | 2025 | 40196117 | PubTator, text mining | PubMed |
| [A Case of Myocardial Dysfunction in a Patient with Recurrent Colon Cancer Treated with Bevacizumab]. | Gan To Kagaku Ryoho | 2025 | 40189771 | PubTator, text mining | PubMed |
| RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression. | Clinics (Sao Paulo) | 2025 | 40187236 | PubTator, text mining | PubMed |
| Oral health and dietary habits: results of the 6th German Oral Health Study (DMS • 6). | Quintessence Int | 2025 | 40091727 | PubTator, text mining | PubMed |
| Regulation of lung cancer initiation and progression by the stem cell determinant Musashi. | Elife | 2025 | 40047406 | PubTator, text mining | PubMed |
| Tumor Mutation Burden Survey of AACR GENIE Database Revealed NTRK (NTRK+) and RET (RET+) Fusions Positive Colorectal Carcinoma (CRC) as Distinct Subsets. | Cancer Med | 2025 | 39950716 | PubTator, text mining | PubMed |
| The adoption of the braided river model toward an inclusive STEM workforce for all. | Mol Biol Cell | 2025 | 39913301 | PubTator, text mining | PubMed |
| IKZF1 promotes pyroptosis and prevents M2 macrophage polarization by inhibiting JAK2/STAT5 pathway in colon cancer. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39862997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=10